Viewing Study NCT03499704


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-25 @ 7:00 PM
Study NCT ID: NCT03499704
Status: UNKNOWN
Last Update Posted: 2023-08-30
First Post: 2018-04-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
Sponsor: Celltrion Pharm, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module